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1. Introduction 
Growth hormone, prolactin and somatolactin belong to the same hormone family and have a 
similar structure in teleost fishes [1]. Each of these three hormones appear to have opposite or 
specific functions in electrolyte balance in teleosts [2]. Teleost fish in freshwater environment 
face two primary challenges: preventing the loss of ions to the external hypoosmotic 
environment and preventing the influx of water. Prolactin plays a central role in these 
activities during the adaptation of fish to fresh water, as evidenced by its ability to increase 
plasma ion concentrations (primarily Na+ and Cl-) and decrease the permeability of 
osmoregulatory organs, such as gill, kidney and intestine [3]. In seawater environment, in 
contrast, diffusive water loss is counteracted by drinking seawater and actively taking up Na+, 
Cl- and water across the gastrointestinal tract, and the gill actively secretes Na+ and Cl- through 
chloride cells. Growth hormone activates these gill chloride cells with ion transporters (e.g., 
Na+, K+-ATPase and the Na+,K+,2Cl- cotransporter) involved in secretion of Na+ and Cl- across 
the branchial epithelium [3], and appears to stimulate the intestinal absorption [4]. On the 
other hand, somatolactin is proposed to be involved in regulation of acid-base, calcium and 
phosphate levels in several species [2, 3, 5-7], but the role of somatolactin in the intestine is 
unknown. Although the presence of receptors for these hormones in ion-transporting organs 
has been reported in a variety of teleost species [8-14] and several studies have investigated the 
direct effects of the teleost hormones on osmoregulatory organs [5, 15-18], the modes of action 
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of the hormones are still unclear. In particular, the opposite in-vitro effects of growth hormone 
and prolactin have not been reported, and there is little information on the cellular and 
biochemical mechanisms of the osmoregulatory actions of these hormones. 
In our in-vivo studies on esophagi from euryhaline fish, prolactin stimulated cell 
proliferation in the epithelium [14, 19]. This effect seems to be related to increased cell 
proliferation for the stratified epithelium to reduce permeability in fresh water [20]. We 
have also found the increased apoptosis for the simple epithelium to give high permeability 
in seawater [14, 19]. A large number of reported effects of prolactin are associated with cell 
proliferation and/or apoptosis [21]. Thyroid-hormone induced apoptosis of the 
metamorphosing amphibian tail is directly prevented by prolactin and enhanced by  
glucocorticoid [22]. Using recently developed techniques for the culture of esophagus from 
the euryhaline medaka, Oryzias latipes, we have demonstrated that cortisol directly induced 
both cell proliferation and apoptosis [23]. In this study, we compared the effects of prolactin, 
growth hormone and somatolactin in this system, and found the first evidence that prolactin 
and growth hormone have opposite effects on the osmoregulatory organ in vitro. 
2. Materials and methods 
2.1. Animals 
Adult medaka (Oryzias latipes, 0.1-0.2 g in weight) of both sexes were kept in indoor 
freshwater tanks at 27 ± 2°C and fed on Tetrafin flakes (Tetra Werke, Melle, Germany) daily 
for more than two weeks. Osmoregulation, differentiation of gill chloride cells, hormonal 
status during adaptation to different salinities, and the in-vivo effects of osmoregulatory 
hormones in this species have been described in our previous reports [23, 24]. Fish were 
exposed to 0.1% Fungizone (Amphotericin B, Invitrogen, Tokyo, Japan) for two days 
without food to avoid contamination before isolation of the esophagus. All fish were 
handled, maintained, and used in accordance with the Guidelines for Animal 
Experimentation established by Okayama University in accordance with international 
standards on animal welfare and in compliance with national regulations. 
2.2. Tissue culture 
As previously described [23], esophagi were gently sliced open along the long axis and cut 
into halves. Each explant was placed in a individual well of 96-well culture plates containing 
preincubation medium (MEM with Hanks' salts, 25 mM HEPES, 5 mg/ml BSA, 250 U/ml 
penicillin G, and 250 µg/ml streptomycin sulfate, adjusted to pH 7.8 at 25°C). After several 
hours, the medium was replaced with MEM containing Earle's salts, 4 mg/ml BSA, 292 
µg/ml L-glutamine, 50 U/ml penicillin G and 50 µg/ml streptomycin sulfate adjusted to pH 
7.8 when saturated with 99% O2 / 1% CO2. The medium osmolarity was adjusted to 300 
mOsm/kg with NaCl. Explants were randomly assigned to control and treatment groups (N 
= 4-6), and incubated at 27°C in an airtight humidified chamber and gassed daily. Chum 
salmon prolactin, growth hormone and somatolactin was (1, 10, 100 ng/ml) or was not 
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added to the culture medium. The concentrations were chosen based on the published 
effective physiological doses [5, 15-17, 25-27], plasma hormone concentrations [14, 28-30], 
and our preliminary studies. These salmonid hormones have approximately 60% amino-acid 
identities to the medaka counterparts (NCBI accession no. or Ensemble medaka genomic 
database browser ID: medaka growth hormone: ENSORLP00000024332, prolactin: AAP33052, 
somatolactin: AAT58046; [1, 13]) and have high specificities for their respective receptors in 
fish, unlike mammalian hormones which bind equally to other hormone receptors in fish [13, 
31, 32]. The use of these salmonid hormones to study the specific physiological roles in many 
teleost species has been well established [25, 27, 29, 33, 34]. All the culture medium was 
replaced with freshly prepared medium daily. Although explants were occasionally found to 
adhere to the bottom of the plate well, they typically remained unattached during culture. 
The tissue culture maintained structural integrity for 8 days based on the presence of 
intact nuclei and cell-to-cell borders [23]. The cultured esophageal explants were fixed in 
4% paraformaldehyde in phosphate-buffered saline (PBS) at 4°C for 4 h for histological 
analysis (N = 3-5) or snap frozen in liquid nitrogen for quantification of apoptosis. 
2.3. Cell proliferation assay 
At given time points, cultured explants were pulsed with an oxidation-reduction indicator 
WST-1 (10% vol/vol, Roche, Tokyo, Japan) for 4 h and color development (A450 nm-A600 nm) 
was quantified to measure the activity of mitochondrial dehydrogenases. This activity is 
proportional to the number of viable cultured cells and is expressed as the cell proliferating 
index [35]. The result after pre-incubation (on day 0) was used to correct for differences in 
initial tissue content per esophageal slice, and also for quantification of apoptosis. 
2.4. Quantification of apoptosis 
DNA internucleosomal fragmentation in the esophagus was assessed using a cell death 
detection ELISA kit (Roche, Tokyo, Japan) according to the manufacturer’s instructions. This 
kit uses a quantitative sandwich ELISA that specifically measures the histone region (H1, H2A, 
H2B, H3, and H4) of mono- and oligonucleosomes [36] in teleosts [37] that are released during 
apoptosis, but not during necrosis [38]. After a 10-minute reaction, color development (A405 
nm-A492 nm) was quantified using an MTP-300 microplate reader (Corona, Ibaragi, Japan).  
2.5. Proliferating cell nuclear antigen (PCNA) immunohistochemistry 
To label proliferating cells in the esophagus, we used a mouse monoclonal antibody (clone 
PC10; Sigma, Tokyo, Japan) against proliferating cell nuclear antigen (PCNA), as described 
previously for teleosts [14, 19, 33]. In our previous study on the teleost esophagus [19], the 
level of PCNA immunoreactivity was in agreement with the uptake of [3H]-thymidine. 
Slides were immersed in 0.3% H2O2 in methanol at 20°C for 30 min to inactivate endogenous 
peroxidase activity. After washing in PBS, the sections were placed in 5% normal goat 
serum in PBS at room temperature for 1 h to block non-specific binding. Sections were 
subsequently incubated at 4°C overnight with the primary antibody diluted 1:100 in a 
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solution containing 0.5% Triton X-100 and 1% BSA (Sigma, Tokyo, Japan) in PBS. Sections 
were then washed 3 times in PBS, incubated with peroxidase-labeled goat anti-mouse 
secondary antibody (Sigma, Tokyo, Japan) diluted 1:70 in PBS containing 0.5% Triton X-100 
and 1% BSA at room temperature for 1 h, and then developed for 5 min with DAB substrate 
solution (Roche, Tokyo, Japan). Controls omitting the PCNA primary antibody were 
performed and yielded no immunoreactivity. 
2.6. In situ 3'-end labeling of DNA (TUNEL) 
Nuclei of apoptotic cells were detected by the TUNEL method [39] using an in situ cell death 
detection kit (Roche, Tokyo, Japan; [14, 19, 33]). The TUNEL procedure produces results that 
are similar to those obtained with analysis of internucleosomal DNA fragmentation in the 
esophagus using gel electrophoresis, and appears to discriminate apoptosis from necrosis 
[19]. Fixed tissue samples were dehydrated through graded alcohol concentrations and 
embedded in Paraplast. Sections were cut at 5 µm and attached to 3-
aminopropyltriethoxysilane-coated slides. The sections were then treated with 20 µg/ml 
proteinase K (Roche, Tokyo, Japan) at 20°C for 30 min, washed in PBS for 15 min, and 
immersed in 0.3% H2O2 in methanol at 20°C for 30 min to inactivate endogenous peroxidase 
activity. After washing in PBS, the sections were incubated with TdT and fluorescein-labeled 
dUTP at 37°C for 1 h in a humidified chamber. The reaction was terminated by transferring 
the slides to PBS for 15 min. The sections were then incubated with peroxidase-labeled anti-
fluorescein antibody at 37°C for 30 min and then for 5 min with DAB substrate solution 
(Roche, Tokyo, Japan). Omission of TdT gave completely negative results. 
2.7. Statistical analysis 
The significance of differences between the means for cell proliferation were analyzed using 
two-way repeated measures analysis of variance (ANOVA), with time within groups (after 
application of treatment) as one factor and treatment among or between groups as the other 
factor. Since there was a significant interaction between treatment and time, each time was 
analyzed separately to identify differences among the treatments using the appropriate 
post-hoc test. The significance of differences among means for concentration-response 
relationships for apoptosis was also tested using ANOVA followed by a post-hoc test. All 
data were checked for normality and equal variances. Where assumptions of normality or 
equal variances were not satisfied, equivalent non-parametric tests were used. Results were 
considered significant for P < 0.05. 
3. Results 
The effects of growth hormone, prolactin and somatolactin (1, 10 and 100 ng/ml) on 
esophageal cell proliferation for 8 days in culture are shown in Figures 1 and 2. Addition of 
prolactin at 10 ng/ml to the culture medium significantly (P < 0.001) enhanced cell proliferation 
after 4 and 8 days (Figs. 1A and 2). Significant (P < 0.05) induction of cell proliferation was also 
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observed at 1 day after treatment with 10 ng/ml growth hormone. In contrast, the esophagus 
did not respond significantly (P > 0.05) to treatment with somatolactin at any concentration. 
Similar results were obtained from six separate trials. Based on the highly significant results 
for prolactin treatment in the cell proliferation assays, the localization of the proliferating cells 
was examined in esophagi cultured for 8 days with or without 10 ng/ml prolactin (Fig. 1B). In 
control esophagi, labeling with an antibody against PCNA revealed few proliferating cell 
nuclei in the epithelium. In contrast, esophagi treated with prolactin had many PCNA-labeled 
nuclei in the epithelium and mucus cells in the epithelium were seemed to be more abundant 
than those in control tissue. No obvious longitudinal regionalization of the epithelial structure, 
including localization of proliferating cells, was observed. 
 
Figure 1. Effects of 1-100 ng/ml growth hormone (GH), prolactin (PRL) and somatolactin (SL) on cell 
proliferation of esophageal explants cultured for 1-8 days (A). Values are means ± SEM (N = 4-6) and are 
expressed in arbitrary units normalized to the results on day 0 (initial tissue content). * P < 0.05, *** P < 
0.001 vs. the control on the same day. Proliferating cell (dark muclei, arrowheads) based on labeling by 
PCNA immunocytochemistry in the esophageal epithelium after 8 days in culture (B). A few PCNA-
positive nuclei were detected in the epithelium in control esophagi, whereas many labeled nuclei 
appeared in the epithelium in esophagi treated with 10 ng/ml prolactin. L: lumen. Representative results 
are shown. Scale bar = 50 µm. 
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Figure 2. Effects of 10 ng/ml growth hormone (GH), prolactin (PRL) and somatolactin (SL) on cell 
proliferation of esophageal explants cultured for 1-8 days (redrawn from Fig. 1). Values are means ± 
SEM (N = 4-6) and are expressed in arbitrary units normalized to the results on day 0 (initial tissue 
content). * P < 0.05, *** P < 0.001 vs. the control on the same day.  
 
Figure 3. Effects of growth hormone (GH), prolactin (PRL) and somatolactin (SL) on esophageal 
apoptosis after 8 days of culture. Values are means ± SEM (N = 4-5) and are expressed in arbitrary units 
normalized to the initial tissue content. * P < 0.05 vs. control. Apoptosis in the esophageal epithelium 
detected in a TUNEL assay after 8 days in culture (left and right insets). A few TUNEL-positive nuclei 
were observed in the epithelium in control esophagi (left inset), whereas numerous labeled nuclei 
appeared in the epithelium of esophagi treated with 10 ng/ml growth hormone (right inset). L: lumen. 
Representative results are shown. Scale bar = 50 µm. 
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We examined the effects of growth hormone, prolactin and somatolactin (1, 10 and 100 
ng/ml) on esophageal apoptosis after 8 days of culture, since esophageal apoptosis has been 
shown to be induced significantly 5-10 days after salinity acclimation and hormonal 
treatment of fish [14, 19, 33]. Addition of growth hormone (10 ng/ml) to the culture medium 
significantly induced esophageal apoptosis (P < 0.05), whereas prolactin and somatolactin 
showed no significant effects at any doses (Fig. 3). Similar results were obtained from three 
separate trials. Based on these results, the localization of apoptotic cells was examined in 
esophagi cultured for 8 days with or without 10 ng/ml growth hormone. In control esophagi 
cultures, there were few apoptotic cells based on TUNEL staining of DNA fragments (Fig. 3, 
left inset), whereas a large number of apoptotic cells were observed in esophageal epithelia 
treated with 10 ng/ml growth hormone for 8 days (Fig. 3, right inset). No obvious 
longitudinal regionalization of apoptotic cells was observed. 
4. Discussion  
Prolactin is an important hormone for freshwater adaptation in teleost species, whereas 
growth hormone is involved in seawater adaptation in several euryhaline fishes [3]. In 
accord with the greater permeability of the esophagus in seawater-acclimated euryhaline 
fish than in freshwater-acclimated fish [20], we have previously shown that apoptosis 
throughout the esophageal epithelium occurs for the simple columnar epithelium in 
seawater and that cell proliferation is induced for the stratified epithelium, which is 
composed of numerous mucus cells, in fresh water [14, 19]. We have also shown that 
injection of prolactin stimulates cell proliferation in the esophageal epithelium [33], but 
neither the mode nor specificity of the action of prolactin is clear. The present study shows 
that the esophagus of medaka is responsive to prolactin and growth hormone after several 
days in culture, with induction of cell proliferation and apoptosis, respectively. This is the 
first demonstration of opposite in-vitro effects of prolactin and growth hormone on the 
teleost osmoregulatory organ. The 10-ng/ml concentrations of prolactin and growth 
hormone required for these specific responses were similar to the physiologically increased 
levels observed in the plasma of several teleost fishes during acclimation to different 
salinities [14, 29, 30]. The time course is also similar to those for esophageal cell proliferation 
and apoptosis as well as for plasma prolactin and growth hormone in euryhaline fishes 
during salinity acclimation and after in-vivo hormonal treatment [14, 19, 33]. The in-vitro 
response to prolactin in the esophagus is consistent with the localization of prolactin 
receptors in proliferating cells of esophageal epithelia found in our previous study [14]. The 
growth hormone receptor is also expressed in the gastrointestinal tracts of fishes, which 
accounts for the ability of growth hormone to act on these organs [8, 11, 40-42]. Taken 
together, these results suggest that the osmoregulatory esophagus is one of the primary 
targets for the actions of prolactin and growth hormone during acclimation of euryhaline 
fishes to fresh water and seawater, respectively. 
The in-vitro effects of prolactin on the permeability of trout gill epithelia [16, 43] may also be 
associated with direct stimulation of cell proliferation by prolactin, as proposed above for 
the medaka esophagus. Prolactin has also been shown to induce cell proliferation in jejunal 
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explants from fetal rat [44], and several studies have shown direct effects of prolactin on cell 
proliferation throughout vertebrates [21]. In teleosts, prolactin induces proliferative 
responses in cultured salmonid leukocytes [25, 26], and promotes osteoblastic activities in 
goldfish scales in vitro [27]. However, the epithelium appears to be the major target, as in 
human keratinocytes and prostate epithelial cells [3, 45, 46], and it is likely that a primary 
function of prolactin in teleost osmoregulation is direct stimulation of cell proliferation in 
osmoregulatory epithelia. On the other hand, prolactin has also been shown to stimulate 
apoptosis in newt spermatogonia and rat luteal tissues [47, 48]. In addition, we suggested 
that the inhibitory effect of prolactin on osteoclastic activity in goldfish scales is mediated in 
part through osteoclast apoptosis [27]. Further studies of intracellular signaling pathway 
will elucidate how prolactin regulates these cell turnover. At any rate, one of prolactin’s 
primary functions may be control of cell proliferation/apoptosis. Indeed, the prolactin 
receptors belong to the large superfamily of class 1 “cytokine” receptors. 
There are few reports on the in vitro actions of growth hormone on teleost osmoregulatory 
organs, although growth hormone appears to be an important hormone for seawater 
adaptation. Direct regulatory roles of growth hormone on the gill Na+,K+-ATPase and heat-
shock protein 70 in climbing perch and silver sea bream have been described [15, 17, 18]. 
Our experiment reveals direct effects of growth hormone on esophageal cell turnover. 
Induction of cell proliferation was observed 1 day after addition of 10 ng/ml growth 
hormone, whereas epithelial apoptosis was stimulated after 8 days. The direct action of growth 
hormone on cell proliferation may occur through locally produced insulin-like growth factor I 
(IGF-I), since IGF-I has been suggested to mediate the direct proliferative effects of growth 
hormone in mammalian gastrointestinal tracts [49, 50]. On the other hand, the stimulation of 
apoptosis by long-term growth hormone exposure is at variance with the commonly reported 
protective role of the growth hormone /IGF-I axis against cell death [51]. However, increases in 
myocyte apoptosis are associated with high levels of growth hormone in patients with 
acromegaly [52] and in 9-month-old transgenic mice overexpressing growth hormone [53]. 
Furthermore, coho salmon implanted with growth hormone for 2 weeks showed stimulated 
Na-dependent proline absorption in the intestine [4], which may reflect increased permeability 
of the apoptotic intestinal epithelia in seawater. 
At 100 ng/ml prolactin or growth hormone, the above significant effects on esophageal cell 
turnover were disappeared. Very high doses of these hormones may also activate receptors 
for the other hormones even in homologous systems. It is reported that prolactin can bind to 
growth hormone receptor in tilapia (Oreochromis mossambicus) [54], and that growth hormone 
has an ability to bind to somatolactin receptor in salmon (Oncorhynchus masou) [13]. In 
addition, our results may also be related to the functional distinction of multiple prolactin 
receptor isoforms in teleost fish [55]. These receptors have different sensitivities to prolactin 
and may have the distinct physiological functions as described above [27, 49, 50, 55-57].  
In our previous study using this esophagus culture system, low levels of cortisol stimulate 
epithelial apoptosis through glucocorticoid receptors in seawater, whereas high levels of 
cortisol induce epithelial cell proliferation also via glucocorticoid receptors in freshwater 
[23]. Interactions of prolactin/growth hormone with glucocorticoid may play an important 
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role in the cell turnover in osmoregulatory esophageal epithelia during acclimation to 
different salinities. In the gill, cortisol is suggested to promote the differentiation of the ion-
secretory chloride cell (seawater-form) with growth hormone, and also expedite the 
differentiation of ion-uptake chloride cell (freshwater-form) by interacting with prolactin [3, 
58]. In the amphibian metamorphosis, on the other hand, thyroid hormones with 
glucocorticoid signaling induce apoptosis in the regression of tadpole tail, whereas prolactin 
prevents this apoptosis [22](Fig. 4B). Although apoptosis by glucocorticoid appear to be 
conserved throughout the vertebrates, thyroid hormone has no significant effect on 
esophageal cell proliferation or apoptosis in euryhaline fish [33]. Therefore, we hypothesize 
that thyroid hormones are involved only in irreversible metamorphosis and/or 
developmental processes. 
 
Figure 4. The summary representation of the epithelial differentiation in the esophagus of an 
euryhaline teleost during adaptation to different salinities. During freshwater (FW) adaptation, 
glucocorticoid signaling (cortisol-glucocorticoid receptor) and prolactin (PRL) stimulate epithelial cell 
proliferation for the stratified epithelium, resulting in the low permeability. During seawater (SW) 
adaptation, growth hormone (GH) and glucocorticoid signaling induce epithelial apoptosis for the 
simple epithelium with the high permeability (A). In the amphibian metamorphosis, thyroid hormones 
with glucocorticoid signaling induce apoptosis in tadpole tail whereas prolactin inhibits the apoptosis 
induced by thyroid hormones in regression of tadpole tail (B). 
5. Conclusions 
Our in vitro study in medaka esophagi indicates that prolactin directly induces the epithelial 
cell proliferation for the stratified epithelium and this response appears to be important in 
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the freshwater adaptive process. Furthermore, growth hormone directly stimulates the 
apoptosis for the simple epithelium and seems to be a key factor in seawater acclimation 
(Fig. 4A). To clarify the mechanism of prolactin/growth hormone actions in osmoregulation, 
future investigations using molecular tools are required to examine the relationship among 
the esophageal proliferating/apoptotic cells and important gene/protein expression patterns 
(e.g. prolactin/ growth hormone receptors, IGF-I and IGF-I receptor as well as 
transporters/pumps and intercellular junctions such as Na+,K+,ATPase, Na+,K+,2Cl- 
cotransporter, aquaporins., tight junctions, gap junctions and claudins. A further study is 
also required determine if the apoptosis induced by growth hormone in medaka esophagus 
is also characteristic of other species. 
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